Perivascular phosphorylated TDP ‐43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin‐4
Brain Pathology · 2025
DOI: 10.1111/bpa.13304 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2025. Verfasst von Jessica Santiago und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cognitive Disorder Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Aquaporin 4, Alzheimer Disease, DNA-Binding Proteins, CD146 Antigen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Greta and Johan Kockska Foundation, Åhlén-stiftelsen, Hjärnfonden.
Themen: Demenz
Abstract (Originalsprache)
The majority of patients with Alzheimer's disease (AD) exhibit aggregates of Trans‐active response DNA binding protein 43 (TDP‐43) in their hippocampus, which is associated with a more aggressive disease progression. The TDP‐43 inclusions are commonly found in neurons, but also in astrocytes. The impact of the inclusions in astrocytes is less known. In the current study, we investigate the presence of phosphorylated TDP‐43 (pTDP‐43) inclusions in astrocytic endfeet and their potential association with blood–brain barrier (BBB) damage, glymphatic system dysfunction, and AD pathology. By staining postmortem hippocampal sections from AD patients and non‐demented controls against TDP‐43 and pTDP‐43 together with the astrocytic markers glial fibrillary acidic protein (GFAP), astrocytic endfeet marker Aquaporin‐4 (AQP4), and markers for BBB alterations (CD146) and leakiness (Immunoglobulin A), we demonstrate a close association between perivascular pTDP‐43 or TDP‐43 inclusions and GFAP or AQP4. These perivascular inclusions were more prominent in AD and correlated with the disease severity and loss of CD146 and AQP4. The findings indicate a relationship between pTDP‐43 accumulation in astrocytic endfeet and BBB and glymphatic system dysfunction, which may contribute to the downstream pathological events seen in AD patients and the aggressive disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cognitive Disorder Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
- Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
ORCID-Profile: Jessica Santiago, Malin Wennström
Förderung
- Greta and Johan Kockska Foundation
- Åhlén-stiftelsen
- Hjärnfonden
- Crafoordska Stiftelsen
- Olle Engkvists Stiftelse
- Dementia Foundation
Zitieren
APA
Santiago, J., Pocevičiūtė, D., Netherlands Brain Bank, & Wennström, M. (2025). Perivascular phosphorylated TDP ‐43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin‐4. Brain Pathology. https://doi.org/10.1111/bpa.13304
Vancouver
Santiago J, Pocevičiūtė D, Netherlands Brain Bank, Wennström M. Perivascular phosphorylated TDP ‐43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin‐4. Brain Pathology. 2025. doi:10.1111/bpa.13304
BibTeX
@article{Santiago2025,
author = {Santiago, Jessica and Pocevičiūtė, Dovilė and Netherlands Brain Bank, Netherlands Brain Bank and Wennström, Malin},
title = {Perivascular phosphorylated TDP ‐43 inclusions are associated with Alzheimer's disease pathology and loss of CD146 and Aquaporin‐4},
journal = {Brain Pathology},
year = {2025},
doi = {10.1111/bpa.13304}
}
EUVIMED